Literature DB >> 24198419

Adeno-associated virus capsid proteins may play a role in transcription and second-strand synthesis of recombinant genomes.

Maxim Salganik1, Fikret Aydemir, Hyun-Joo Nam, Robert McKenna, Mavis Agbandje-McKenna, Nicholas Muzyczka.   

Abstract

A group of four interacting amino acids in adeno-associated virus type 8 (AAV8) called the pH quartet has been shown to undergo a structural change when subjected to acidic pH comparable to that seen in endosomal compartments. We examined the phenotypes of mutants with mutations in these amino acids as well as several nearby residues in the background of AAV2. We found that three of the mutations in this region (Y704A, E562A, and E564A) produce normal titers of mature capsids but are extremely defective for transduction (>10(7)-fold). The remaining mutants were also defective for transduction, but the defect in these mutants (E563A, E561A, H526A, and R389A) is not as severe (3- to 22-fold). Two other mutants (Y700A and Y730A) were found to be defective for virus assembly. One of the extremely defective mutants (Y704A) was found to enter the cell, traffic to the nucleus, and uncoat its DNA nearly as efficiently as the wild type. This suggested that some step after nuclear entry and uncoating was defective. To see if the extremely defective mutants were impaired in second-strand synthesis, the Y704A, E562A, and E564A mutants containing self-complementary DNA were compared with virus containing single-stranded genomes. Two of the mutants (Y704A and E564A) showed 1-log and 3-log improvements in infectivity, respectively, while the third mutant (E562A) showed no change. This suggested that inhibition of second-strand synthesis was responsible for some but not most of the defect in these mutants. Comparison of Y704A mRNA synthesis with that of the wild-type capsid showed that accumulation of steady-state mRNA in the Y704A mutant was reduced 450-fold, even though equal genome numbers were uncoated. Our experiments have identified a novel capsid function. They suggest that AAV capsids may play a role in the initiation of both second-strand synthesis and transcription of the input genome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24198419      PMCID: PMC3911664          DOI: 10.1128/JVI.02093-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization.

Authors:  Michael A Lochrie; Gwen P Tatsuno; Brian Christie; Jennifer Wellman McDonnell; Shangzhen Zhou; Richard Surosky; Glenn F Pierce; Peter Colosi
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus.

Authors:  Florian Sonntag; Svenja Bleker; Barbara Leuchs; Roger Fischer; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

3.  Separate basic region motifs within the adeno-associated virus capsid proteins are essential for infectivity and assembly.

Authors:  Joshua C Grieger; Stephen Snowdy; Richard J Samulski
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.

Authors:  Giridhara R Jayandharan; Li Zhong; Brandon K Sack; Angela E Rivers; Mengxin Li; Baozheng Li; Roland W Herzog; Arun Srivastava
Journal:  Hum Gene Ther       Date:  2010-03       Impact factor: 5.695

5.  Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus.

Authors:  Jarrod S Johnson; R Jude Samulski
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

6.  Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo.

Authors:  G R Jayandharan; L Zhong; B Li; B Kachniarz; A Srivastava
Journal:  Gene Ther       Date:  2008-05-22       Impact factor: 5.250

7.  Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses.

Authors:  Li Zhong; Baozheng Li; Cathryn S Mah; Lakshmanan Govindasamy; Mavis Agbandje-McKenna; Mario Cooper; Roland W Herzog; Irene Zolotukhin; Kenneth H Warrington; Kirsten A Weigel-Van Aken; Jacqueline A Hobbs; Sergei Zolotukhin; Nicholas Muzyczka; Arun Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-29       Impact factor: 11.205

8.  Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression.

Authors:  Li Zhong; Baozheng Li; Giridhararao Jayandharan; Cathryn S Mah; Lakshmanan Govindasamy; Mavis Agbandje-McKenna; Roland W Herzog; Kirsten A Weigel-Van Aken; Jacqueline A Hobbs; Sergei Zolotukhin; Nicholas Muzyczka; Arun Srivastava
Journal:  Virology       Date:  2008-10-02       Impact factor: 3.616

9.  Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions.

Authors:  Joshua C Grieger; Jarrod S Johnson; Brittney Gurda-Whitaker; Mavis Agbandje-McKenna; R Jude Samulski
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

10.  A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8.

Authors:  Bassel Akache; Dirk Grimm; Xuan Shen; Sally Fuess; Stephen R Yant; Dariya S Glazer; Julie Park; Mark A Kay
Journal:  Mol Ther       Date:  2007-02       Impact factor: 11.454

View more
  30 in total

Review 1.  E Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV Evolution.

Authors:  Dirk Grimm; Sergei Zolotukhin
Journal:  Mol Ther       Date:  2015-09-21       Impact factor: 11.454

Review 2.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

Review 3.  Gene therapy for neurological disorders: progress and prospects.

Authors:  Benjamin E Deverman; Bernard M Ravina; Krystof S Bankiewicz; Steven M Paul; Dinah W Y Sah
Journal:  Nat Rev Drug Discov       Date:  2018-08-10       Impact factor: 84.694

4.  Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2.

Authors:  Antonette Bennett; Annahita Keravala; Victoria Makal; Justin Kurian; Brahim Belbellaa; Rangoli Aeran; Yu-Shan Tseng; Duncan Sousa; John Spear; Mehdi Gasmi; Mavis Agbandje-McKenna
Journal:  J Struct Biol       Date:  2019-12-16       Impact factor: 2.867

5.  Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors.

Authors:  Benjamin S Schuster; Anthony J Kim; Joshua C Kays; Mia M Kanzawa; William B Guggino; Michael P Boyle; Steven M Rowe; Nicholas Muzyczka; Jung Soo Suk; Justin Hanes
Journal:  Mol Ther       Date:  2014-05-29       Impact factor: 11.454

6.  An essential N-terminal serine-rich motif in the AAV VP1 and VP2 subunits that may play a role in viral transcription.

Authors:  Tawana M Robinson; Michelle L Ho; Brian Wahlig; Veronica Gough; Anton Banta; Kiara Reyes Gamas; Byunguk Kang; Esther Lee; Weitong Chen; Junghae Suh
Journal:  Virology       Date:  2020-04-25       Impact factor: 3.616

7.  Adeno-Associated Virus Genome Interactions Important for Vector Production and Transduction.

Authors:  Anna C Maurer; Matthew D Weitzman
Journal:  Hum Gene Ther       Date:  2020-05       Impact factor: 5.695

8.  Structure of neurotropic adeno-associated virus AAVrh.8.

Authors:  Sujata Halder; Kim Van Vliet; J Kennon Smith; Thao Thi Phuong Duong; Robert McKenna; James M Wilson; Mavis Agbandje-McKenna
Journal:  J Struct Biol       Date:  2015-08-31       Impact factor: 2.867

Review 9.  Cellular transduction mechanisms of adeno-associated viral vectors.

Authors:  Garrett Edward Berry; Aravind Asokan
Journal:  Curr Opin Virol       Date:  2016-08-18       Impact factor: 7.090

10.  GPR108 Is a Highly Conserved AAV Entry Factor.

Authors:  Amanda M Dudek; Nerea Zabaleta; Eric Zinn; Sirika Pillay; James Zengel; Caryn Porter; Jennifer Santos Franceschini; Reynette Estelien; Jan E Carette; Guo Ling Zhou; Luk H Vandenberghe
Journal:  Mol Ther       Date:  2019-11-13       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.